Clinical Trial Update: TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study of Telitacicept in inflammatory myopathies is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathy

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Zhongming Qiu | Conditions: Inflammatory Myopathy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING